Power Law company profile

Bluebird bio

Biotech & Life Sciences · Cambridge, United States · Founded 1993 · IPO 2013 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$150M

Market cap · 2026

Revenue

$84M

Latest reported FY

Investors

10 investors on Bluebird bio's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 10 investors entered at this stage

Global footprint

AI talent share

0.6% of workforce is AI talent
(2 of 323 staff)

Core AI10.31%

Other AI10.31%

Non-AI workforce32199.38%

Web traffic by country

1.7K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo